4D Molecular Therapeutics (NASDAQ:FDMT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does 4D Molecular Therapeutics (FDMT) operate in?

4D Molecular Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

4D Molecular Therapeutics Stock (NASDAQ: FDMT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 838.69K
Day Range	- - -
52 Wk Range	7.32 - 36.25
Market Cap	$388.78M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	18.42%
Days to Cover	11.03

Recent News

4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate

4D Molecular Therapeutics stock drops after the company shared interim data from the PRISM Phase 1/2 trial and details on its Phase 3 4FRONT study for wet AMD. The Phase 3 study comparing 4D-150 to Regeneron's Eylea is set to begin in Q1 2025.

Vandana Singh

Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Avi Kapoor

4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate

4D Molecular Therapeutics reports 24-week interim data from its PRISM Phase 2 trial, showing 77% of wet AMD patients injection-free with 4D-150. The trial highlights safety and efficacy in reducing anti-VEGF treatments.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 838.69K
Day Range	- - -
52 Wk Range	7.32 - 36.25
Market Cap	$388.78M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	18.42%
Days to Cover	11.03

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy 4D Molecular Therapeutics (FDMT) stock?

You can purchase shares of 4D Molecular Therapeutics (NASDAQ:FDMT) through any online brokerage.

View our list of the best stock brokerages

Who are 4D Molecular Therapeutics (FDMT) competitors?

Other companies in 4D Molecular Therapeutics’s space includes: Valneva (NASDAQ:VALN), Larimar Therapeutics (NASDAQ:LRMR), Tango Therapeutics (NASDAQ:TNGX), Sangamo Therapeutics (NASDAQ:SGMO) and Silence Therapeutics (NASDAQ:SLN).

What is the forecast, or price target, for 4D Molecular Therapeutics (FDMT) stock?

4D Molecular Therapeutics has a consensus price target of $39.45.

What is the current price for 4D Molecular Therapeutics (FDMT)?

The stock price for 4D Molecular Therapeutics (NASDAQ: FDMT) is $8.41 last updated November 20, 2024 at 5:06 PM EST.

Does 4D Molecular Therapeutics (FDMT) pay a dividend?

There are no upcoming dividends for 4D Molecular Therapeutics.

When is 4D Molecular Therapeutics (NASDAQ:FDMT) reporting earnings?

4D Molecular Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is 4D Molecular Therapeutics (FDMT) going to split?

There is no upcoming split for 4D Molecular Therapeutics.

What sector and industry does 4D Molecular Therapeutics (FDMT) operate in?

4D Molecular Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

4D Molecular Therapeutics

4D Molecular Therapeutics (FDMT) Forecast